All the information you need about BIO ALIGRE to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2023-04-26 | Partially confidential | 2022-09-30 | Complete |
| 2022-04-28 | Partially confidential | 2018-09-30 | Complete |
| 2022-04-12 | Partially confidential | 2017-09-30 | Complete |
| Name | BIO ALIGRE |
| Siren | 811834449 |
| Closing | 2018-09-30 |
| Registry code | 7501 |
| Registration number | 39481 |
| Management number | 2015B23727 |
| Activity code | 4711B |
| Closing date n-1 | 1901-01-01 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2022-04-28 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Partially confidential |
| Address | 75012 PARIS |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
AB Establishment Expenses | 12 714.00 | 7 174.00 | 5 540.00 | 12 714.00 |
AF Concessions, Patents and Similar Rights | 34 200.00 | 34 200.00 | 34 200.00 | |
AH Goodwill | 403 135.00 | 403 135.00 | 403 135.00 | |
AP Buildings | 171 065.00 | 48 613.00 | 122 452.00 | 171 065.00 |
AR Technical installations, industrial equipment and tools | 33 073.00 | 13 542.00 | 19 530.00 | 33 073.00 |
AT Other tangible assets | 138 535.00 | 57 576.00 | 80 958.00 | 138 535.00 |
BB Receivables related to investments | 7 675.00 | 7 675.00 | 7 675.00 | |
BH Other financial assets | 18 518.00 | 18 516.00 | 18 518.00 | |
BJ TOTAL (I) | 905 641.00 | 126 906.00 | 778 734.00 | 905 641.00 |
BT Goods | 58 689.00 | 58 689.00 | 58 689.00 | |
BX Customers and related accounts | 403.00 | 403.00 | 403.00 | |
BZ Other receivables | 24 831.00 | 24 831.00 | 24 831.00 | |
CD Marketable securities | 167.00 | 167.00 | 167.00 | |
CF Cash and cash equivalents | 90 400.00 | 90 400.00 | 90 400.00 | |
CH Prepaid expenses | 5 064.00 | 5 064.00 | 5 064.00 | |
CJ TOTAL (II) | 179 555.00 | 179 555.00 | 179 555.00 | |
CO Grand total (0 to V) | 1 085 196.00 | 126 906.00 | 958 290.00 | 1 085 196.00 |
CU Other investments | 86 723.00 | 86 723.00 | 86 723.00 | |
CX Development or Research and Development Expenses | 1.00 | 1.00 | ||
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 30 000.00 | 30 000.00 | ||
DD Legal reserve (1) | 3 000.00 | 3 000.00 | ||
DH Retained earnings | -17 369.00 | -17 369.00 | ||
DI RESULTS FOR THE YEAR (Profit or Loss) | 70 693.00 | 70 693.00 | ||
DL TOTAL (I) | 83 324.00 | 83 324.00 | ||
DU Loans and Debts from Credit Institutions (3) | 325 267.00 | 325 267.00 | ||
DV Miscellaneous Loans and Financial Debts (4) | 369 632.00 | 369 632.00 | ||
DX Trade payables and related accounts | 124 034.00 | 124 034.00 | ||
DY Tax and social security liabilities | 56 031.00 | 56 031.00 | ||
EC TOTAL (IV) | 874 965.00 | 874 965.00 | ||
EE Grand total (I to V) | 958 290.00 | 958 290.00 | ||
EG Accrued income and payables due within one year | 272 974.00 | 272 974.00 | ||
